CTSO · Categories · Form 4

CTSO - SEC Form 4 insider transactions

Cytosorbents Corporation (CTSO) sec form 4 insider transactions - real-time wire coverage filtered to Form 4 only.

Recent Form 4 for CTSO

• 200d
  Chief Executive Officer Chan Phillip P. was granted 100,000 shares, increasing direct ownership by 7% to 1,482,963 units (SEC Form 4)

  4 - Cytosorbents Corp (0001175151) (Issuer)
• 304d
  Chief Executive Officer Chan Phillip P. was granted 105,600 shares, increasing direct ownership by 8% to 1,382,963 units (SEC Form 4)

  4 - Cytosorbents Corp (0001175151) (Issuer)
• 304d
  SEC Form 4 filed by Director Jones Edward Raymond

  4 - Cytosorbents Corp (0001175151) (Issuer)
• 304d
  SEC Form 4 filed by Director Bator Michael G.

  4 - Cytosorbents Corp (0001175151) (Issuer)
• 304d
  Chief Financial Officer Mariani Peter J was granted 71,500 shares, increasing direct ownership by 15% to 538,113 units (SEC Form 4)

  4 - Cytosorbents Corp (0001175151) (Issuer)
• 304d
  SEC Form 4 filed by Director Kim Jiny

  4 - Cytosorbents Corp (0001175151) (Issuer)
• 304d
  President and COO Capponi Vincent was granted 89,100 shares, increasing direct ownership by 13% to 766,268 units (SEC Form 4)

  4 - Cytosorbents Corp (0001175151) (Issuer)
• 304d
  Chief Medical Officer Deliargyris Efthymios was granted 70,000 shares, increasing direct ownership by 17% to 473,025 units (SEC Form 4)

  4 - Cytosorbents Corp (0001175151) (Issuer)
• 304d
  SEC Form 4 filed by Director Sobel Alan D.

  4 - Cytosorbents Corp (0001175151) (Issuer)
• 461d
  Director Bator Michael G. increased direct ownership by 7% to 151,273 units (SEC Form 4)

  4 - Cytosorbents Corp (0001175151) (Issuer)
• 467d
  President and COO Capponi Vincent increased direct ownership by 2% to 677,168 units (SEC Form 4)

  4 - Cytosorbents Corp (0001175151) (Issuer)
• 467d
  Chief Financial Officer Mariani Peter J increased direct ownership by 8% to 466,613 units (SEC Form 4)

  4 - Cytosorbents Corp (0001175151) (Issuer)
• 467d
  Chief Executive Officer Chan Phillip P. increased direct ownership by 3% to 1,277,363 units (SEC Form 4)

  4 - Cytosorbents Corp (0001175151) (Issuer)
• 467d
  Director Sobel Alan D. increased direct ownership by 18% to 145,757 units (SEC Form 4)

  4 - Cytosorbents Corp (0001175151) (Issuer)
• 502d
  Director Bator Michael G. exercised 15,879 in-the-money shares at a strike of $1.00, increasing direct ownership by 13% to 141,273 units (SEC Form 4)

  4 - Cytosorbents Corp (0001175151) (Issuer)
• 502d
  President and COO Capponi Vincent exercised 31,760 in-the-money shares at a strike of $1.00, increasing direct ownership by 5% to 665,168 units (SEC Form 4)

  4 - Cytosorbents Corp (0001175151) (Issuer)
• 502d
  Chief Medical Officer Deliargyris Efthymios exercised 16,233 in-the-money shares at a strike of $1.00, increasing direct ownership by 4% to 403,025 units (SEC Form 4)

  4 - Cytosorbents Corp (0001175151) (Issuer)
• 502d
  Director Sobel Alan D. exercised 21,950 in-the-money shares at a strike of $1.00, increasing direct ownership by 22% to 123,807 units (SEC Form 4)

  4 - Cytosorbents Corp (0001175151) (Issuer)
• 502d
  Chief Executive Officer Chan Phillip P. exercised 90,832 in-the-money shares at a strike of $1.00, increasing direct ownership by 8% to 1,243,195 units (SEC Form 4)

  4 - Cytosorbents Corp (0001175151) (Issuer)
• 502d
  Chief Financial Officer Mariani Peter J exercised 32,625 in-the-money shares at a strike of $1.00, increasing direct ownership by 8% to 433,988 units (SEC Form 4)

  4 - Cytosorbents Corp (0001175151) (Issuer)
• 608d
  SEC Form 4 filed by Chief Medical Officer Deliargyris Efthymios

  4 - Cytosorbents Corp (0001175151) (Issuer)
• 608d
  SEC Form 4 filed by President and COO Capponi Vincent

  4 - Cytosorbents Corp (0001175151) (Issuer)
• 661d
  Chief Financial Officer Mariani Peter J was granted 350,000 shares (SEC Form 4)

  4 - Cytosorbents Corp (0001175151) (Issuer)
• 795d
  Deliargyris Efthymios was granted 61,000 shares, increasing direct ownership by 18% to 409,433 units (SEC Form 4)

  4 - Cytosorbents Corp (0001175151) (Issuer)
• 795d
  SEC Form 4 filed by Jones Edward Raymond

  4 - Cytosorbents Corp (0001175151) (Issuer)
• 795d
  SEC Form 4 filed by Sobel Alan D.

  4 - Cytosorbents Corp (0001175151) (Issuer)
• 795d
  Bloch Kathleen P. was granted 65,000 shares, increasing direct ownership by 14% to 532,941 units (SEC Form 4)

  4 - Cytosorbents Corp (0001175151) (Issuer)
• 795d
  SEC Form 4 filed by Bator Michael G.

  4 - Cytosorbents Corp (0001175151) (Issuer)
• 795d
  Capponi Vincent was granted 81,000 shares, increasing direct ownership by 14% to 665,134 units (SEC Form 4)

  4 - Cytosorbents Corp (0001175151) (Issuer)
• 795d
  SEC Form 4 filed by Kim Jiny

  4 - Cytosorbents Corp (0001175151) (Issuer)
• 795d
  Chan Phillip P. was granted 96,000 shares, increasing direct ownership by 9% to 1,164,704 units (SEC Form 4)

  4 - Cytosorbents Corp (0001175151) (Issuer)
• 797d
  SEC Form 4 filed by Deliargyris Efthymios

  4 - Cytosorbents Corp (0001175151) (Issuer)
• 797d
  SEC Form 4 filed by Capponi Vincent

  4 - Cytosorbents Corp (0001175151) (Issuer)
• 797d
  SEC Form 4 filed by Bloch Kathleen P.

  4 - Cytosorbents Corp (0001175151) (Issuer)
• 797d
  SEC Form 4 filed by Chan Phillip P.

  4 - Cytosorbents Corp (0001175151) (Issuer)
• 992d
  SEC Form 4: Bloch Kathleen P. was granted 45,000 shares, increasing direct ownership by 11% to 442,347 units

  4 - Cytosorbents Corp (0001175151) (Issuer)
• 1035d
  SEC Form 4: Bator Michael G. bought $9,580 worth of shares (3,000 units at $3.19), increasing direct ownership by 4% to 87,800 units

  4 - Cytosorbents Corp (0001175151) (Issuer)
• 1063d
  SEC Form 4 filed by Bloch Kathleen P.

  4 - Cytosorbents Corp (0001175151) (Issuer)
• 1063d
  SEC Form 4 filed by Chan Phillip P.

  4 - Cytosorbents Corp (0001175151) (Issuer)
• 1063d
  SEC Form 4 filed by Sobel Alan D.

  4 - Cytosorbents Corp (0001175151) (Issuer)
• 1063d
  SEC Form 4 filed by Bator Michael G.

  4 - Cytosorbents Corp (0001175151) (Issuer)
• 1063d
  SEC Form 4 filed by Jones Edward Raymond

  4 - Cytosorbents Corp (0001175151) (Issuer)
• 1063d
  SEC Form 4 filed by Kim Jiny

  4 - Cytosorbents Corp (0001175151) (Issuer)
• 1063d
  SEC Form 4 filed by Capponi Vincent

  4 - Cytosorbents Corp (0001175151) (Issuer)
• 1063d
  SEC Form 4 filed by Deliargyris Efthymios

  4 - Cytosorbents Corp (0001175151) (Issuer)
• 1105d
  SEC Form 4 filed by Bloch Kathleen P.

  4 - Cytosorbents Corp (0001175151) (Issuer)
• 1124d
  SEC Form 4 filed by Bloch Kathleen P.

  4 - Cytosorbents Corp (0001175151) (Issuer)
• 1160d
  SEC Form 4 filed by Capponi Vincent

  4 - Cytosorbents Corp (0001175151) (Issuer)
• 1160d
  SEC Form 4 filed by Chan Phillip P.

  4 - Cytosorbents Corp (0001175151) (Issuer)
• 1195d
  SEC Form 4: Sobel Alan D. received a gift of 2,000 shares and gifted 2,000 shares, increasing direct ownership by 3% to 81,300 units

  4 - Cytosorbents Corp (0001175151) (Issuer)
• 1217d
  SEC Form 4: Kraus Al exercised 12,000 shares at a strike of $2.65, increasing direct ownership by 9% to 142,046 units

  4 - Cytosorbents Corp (0001175151) (Issuer)
• 1277d
  SEC Form 4: Chan Phillip P. bought $7,382 worth of shares (5,859 units at $1.26), increasing direct ownership by 0.66% to 897,279 units

  4 - Cytosorbents Corp (0001175151) (Issuer)
• 1278d
  SEC Form 4: Chan Phillip P. bought $30,475 worth of shares (24,141 units at $1.26), increasing direct ownership by 3% to 891,420 units

  4 - Cytosorbents Corp (0001175151) (Issuer)
• 1365d
  SEC Form 4: Chan Phillip P. bought $59,500 worth of shares (35,000 units at $1.70), increasing direct ownership by 4% to 867,279 units

  4 - Cytosorbents Corp (0001175151) (Issuer)
• 1382d
  SEC Form 4: Kim Jiny bought $1,910 worth of shares (1,000 units at $1.91), increasing direct ownership by 1% to 70,300 units

  4 - Cytosorbents Corp (0001175151) (Issuer)
• 1396d
  SEC Form 4 filed by Sobel Alan D.

  4 - Cytosorbents Corp (0001175151) (Issuer)
• 1396d
  SEC Form 4 filed by Kim Jiny

  4 - Cytosorbents Corp (0001175151) (Issuer)
• 1396d
  SEC Form 4 filed by Jones Edward Raymond

  4 - Cytosorbents Corp (0001175151) (Issuer)
• 1396d
  SEC Form 4 filed by Bator Michael G.

  4 - Cytosorbents Corp (0001175151) (Issuer)
• 1396d
  SEC Form 4 filed by Kraus Al

  4 - Cytosorbents Corp (0001175151) (Issuer)

Other CTSO categories

• 8-K
• 10-K
• 10-Q
• S-1
• 13D
• 13G
• Form 3
• Form 5
• DEF 14A
• M&A
• Earnings
• Dividends